|
|
|||||||||
CA: A Cancer Journal for Clinicians, Vol 46, Issue 1 46-63, Copyright © 1996 by American Cancer Society
D. M. Green, G. J. D'Angio, J. B. Beckwith, N. E. Breslow, P. E. Grundy, M. L. Ritchey and P. R. Thomas
Wilms tumor is the most common primary malignant renal tumor of childhood,
representing about six percent of all childhood cancers in the United
States. Developments in surgery, radiation therapy, and chemotherapy have
led to a dramatic change in the prognosis for most patients, and Wilms
tumor has become a paradigm for multimodal treatment of a pediatric
malignant solid tumor. The authors review the progress made in the
diagnosis and management of children with Wilms tumor.
ARTICLES
Wilms tumor
Department of Pediatrics, Roswell Park Cancer Institute, Buffalo, New York, USA.
This article has been cited by other articles:
![]() |
J. S. Dome, S. Chung, T. Bergemann, C. B. Umbricht, M. Saji, L. A. Carey, P. E. Grundy, E. J. Perlman, N. E. Breslow, and S. Sukumar High Telomerase Reverse Transcriptase (hTERT) Messenger RNA Level Correlates with Tumor Recurrence in Patients with Favorable Histology Wilms' Tumor Cancer Res., September 1, 1999; 59(17): 4301 - 4307. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | COVER ARCHIVE | SEARCH | TABLE OF CONTENTS |